Black Rock Inc. Sc Pharmaceuticals Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,768,669 shares of SCPH stock, worth $6.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,768,669

Previous 1,801,610 1.83%

Holding current value

$6.05 Million

Previous $9.04 Million 14.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.51 - $5.21 $115,622 - $171,622	-32,941 Reduced 1.83%	1,768,669 $7.69 Million
Q1 2024 May 10, 2024	SELL	$4.86 - $6.39 $300,488 - $395,087	-61,829 Reduced 3.32%	1,801,610 $9.04 Million
Q4 2023 Feb 13, 2024	BUY	$4.7 - $6.63 $631,299 - $890,534	134,319 Added 7.77%	1,863,439 $11.7 Million
Q3 2023 Nov 13, 2023	SELL	$7.0 - $9.82 $2,156 - $3,024	-308 Reduced 0.02%	1,729,120 $12.3 Million
Q2 2023 Aug 11, 2023	BUY	$8.94 - $11.74 $14.5 Million - $19 Million	1,617,539 Added 1445.66%	1,729,428 $17.6 Million
Q1 2023 May 12, 2023	BUY	$5.59 - $9.47 $266,793 - $451,974	47,727 Added 74.39%	111,889 $1.01 Million
Q4 2022 Feb 13, 2023	SELL	$4.02 - $7.53 $2,572 - $4,819	-640 Reduced 0.99%	64,162 $460,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.52 $62 - $91	14 Added 0.02%	64,802 $422,000
Q2 2022 Aug 12, 2022	BUY	$4.3 - $6.48 $29,691 - $44,744	6,905 Added 11.93%	64,788 $313,000
Q1 2022 May 12, 2022	SELL	$3.9 - $6.11 $6,247 - $9,788	-1,602 Reduced 2.69%	57,883 $329,000
Q4 2021 Feb 10, 2022	BUY	$3.88 - $6.9 $5,354 - $9,522	1,380 Added 2.38%	59,485 $298,000
Q3 2021 Nov 09, 2021	SELL	$4.93 - $7.15 $20,173 - $29,257	-4,092 Reduced 6.58%	58,105 $387,000
Q2 2021 Aug 11, 2021	BUY	$5.19 - $7.38 $322,802 - $459,013	62,197 New	62,197 $380,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $93.7M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account